This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tonghua Dongbao Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Nan Zhang in Pharmaceutical Development
Introduction
Nan Zhang is a prominent inventor based in Jilin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable drug formulations. His work is characterized by a focus on improving the stability and efficacy of injectable medications.
Latest Patents
One of Nan Zhang's notable patents is for a stable secukinumab injection and its preparation method. This innovative formulation includes ingredients such as 50 mg/ml-300 mg/ml of secukinumab, histidine, methionine, a low-sugar alcohol, and polysorbate 80, with water for injection as the balance. The pH of the solution is maintained between 5.0 and 7.0. Stability tests have demonstrated that this formulation exhibits superior quality compared to commercial varieties available in the market. The indicators of this stable secukinumab injection meet the relevant regulations of the Chinese Pharmacopoeia, showcasing its promising application prospects.
Career Highlights
Nan Zhang is currently associated with Tonghua Dongbao Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His expertise in drug formulation has positioned him as a key figure in the development of new therapeutic options.
Collaborations
Nan Zhang collaborates with talented professionals in his field, including colleagues such as Depeng Wang and Xindan Fan. These collaborations enhance the research and development efforts at Tonghua Dongbao Pharmaceutical Co., Ltd.
Conclusion
Nan Zhang's contributions to pharmaceutical innovations, particularly through his patent for a stable secukinumab injection, highlight his role as a leading inventor in the industry. His work not only advances drug stability but also promises to improve patient outcomes in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile